참고문헌
- Brooks, A.N., Choi, P.S., de Waal, L., Sharifnia, T., Imielinski, M., Saksena, G., Pedamallu, C.S., Sivachenko, A., Rosenberg, M., Chmielecki, J., et al. (2014). A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One 9, e87361. https://doi.org/10.1371/journal.pone.0087361
- Damm, F., Kosmider, O., Gelsi-Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della Valle, V., Couronne, L., Scourzic, L., Chesnais, V., et al. (2012). Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 119, 3211-3218. https://doi.org/10.1182/blood-2011-12-400994
- Duijf, P.H. and Benezra, R. (2013). The cancer biology of wholechromosome instability. Oncogene 32, 4727-4736. https://doi.org/10.1038/onc.2012.616
- Fu, Y., Masuda, A., Ito, M., Shinmi, J. and Ohno, K. (2011). AGdependent 3-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon. Nucleic Acids Res. 39, 4396-4404. https://doi.org/10.1093/nar/gkr026
- Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004). A census of human cancer genes. Nat. Rev. Cancer 4, 177-183. https://doi.org/10.1038/nrc1299
- Graubert, T.A., Shen, D., Ding, L., Okeyo-Owuor, T., Lunn, C.L., Shao, J., Krysiak, K., Harris, C.C., Koboldt, D.C., Larson, D.E., et al. (2012). Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. 44, 53-57. https://doi.org/10.1038/ng.1031
- Ilagan, J.O., Ramakrishnan, A., Hayes, B., Murphy, M.E., Zebari, A.S., Bradley, P. and Bradley, R.K. (2015). U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 25, 14-26. https://doi.org/10.1101/gr.181016.114
- Imielinski, M., Berger, A.H., Hammerman, P.S., Hernandez, B., Pugh, T.J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012). Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120. https://doi.org/10.1016/j.cell.2012.08.029
- Jung, Y., Jun, Y., Lee, H.Y., Kim, S., Jung, Y., Keum, J., Lee, Y.S., Cho, Y.B., Lee, S. and Kim, J. (2015). Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer. Oncotarget 6, 25368-25380.
- Kim, J., Lo, L., Dormand, E. and Anderson, D.J. (2003). SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17-31. https://doi.org/10.1016/S0896-6273(03)00163-6
- Makishima, H., Visconte, V., Sakaguchi, H., Jankowska, A.M., Abu Kar, S., Jerez, A., Przychodzen, B., Bupathi, M., Guinta, K., Afable, M.G., et al. (2012). Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119, 3203-3210. https://doi.org/10.1182/blood-2011-12-399774
- Network, T.C.G.A.R. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543-550. https://doi.org/10.1038/nature13385
- Pacheco, T.R., Moita, L.F., Gomes, A.Q., Hacohen, N. and Carmo-Fonseca, M. (2006). RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts. Mol. Biol. Cell 17, 4187-4199. https://doi.org/10.1091/mbc.e06-01-0036
- Park, S.M., Ou, J., Chamberlain, L., Simone, T.M., Yang, H., Virbasius, C.M., Ali, A.M., Zhu, L.J., Mukherjee, S., Raza, A., et al. (2016). U2AF35(S34F) Promotes transformation by directing aberrant ATG7 Pre-mRNA 3' end formation. Mol. Cell 62, 479-490. https://doi.org/10.1016/j.molcel.2016.04.011
- Przychodzen, B., Jerez, A., Guinta, K., Sekeres, M.A., Padgett, R., Maciejewski, J.P. and Makishima, H. (2013). Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood 122, 999-1006. https://doi.org/10.1182/blood-2013-01-480970
- Qian, J., Yao, D.M., Lin, J., Qian, W., Wang, C.Z., Chai, H.Y., Yang, J., Li, Y., Deng, Z.Q., Ma, J.C., et al. (2012). U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 7, e45760. https://doi.org/10.1371/journal.pone.0045760
- Roschke, A.V. and Rozenblum, E. (2013). Multi-layered cancer chromosomal instability phenotype. Front Oncol. 3, 302.
- Shirai, C.L., Ley, J.N., White, B.S., Kim, S., Tibbitts, J., Shao, J., Ndonwi, M., Wadugu, B., Duncavage, E.J., Okeyo-Owuor, T., et al. (2015). Mutant U2AF1 expression alters hmatopoiesis and pre-mRNA splicing in vivo. Cancer Cell 27, 631-643. https://doi.org/10.1016/j.ccell.2015.04.008
- Thol, F., Kade, S., Schlarmann, C., Loffeld, P., Morgan, M., Krauter, J., Wlodarski, M.W., Kolking, B., Wichmann, M., Gorlich, K., et al. (2012). Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119, 3578-3584. https://doi.org/10.1182/blood-2011-12-399337
- Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011). Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64-69. https://doi.org/10.1038/nature10496
피인용 문헌
- Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features vol.11, pp.10, 2018, https://doi.org/10.3390/cancers11101439
- Elucidation of the aberrant 3′ splice site selection by cancer-associated mutations on the U2AF1 vol.11, pp.1, 2018, https://doi.org/10.1038/s41467-020-18559-6
- Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles vol.5, pp.1, 2018, https://doi.org/10.1038/s41525-019-0108-5
- The GENDULF algorithm: mining transcriptomics to uncover modifier genes for monogenic diseases vol.16, pp.12, 2020, https://doi.org/10.15252/msb.20209701
- CtIP-mediated alternative mRNA splicing fine-tunes the DNA damage response vol.27, pp.3, 2018, https://doi.org/10.1261/rna.078519.120